Medtronic and Abbott Join Forces: Groundbreaking CGM Partnership for Diabetes Care

In this episode of 'Diabetics Doing Things,' we delve into the surprising partnership between industry giants Medtronic and Abbott. On August 7th, they announced their collaboration on a Continuous Glucose Monitoring (CGM) system, combining Abbott's advanced Freestyle Libre 3 technology with Medtronic's insulin delivery devices.

We discuss the press releases from both companies, the strategic alignment that led to this partnership, and hear insights from Ali Dianaty, Senior VP at Medtronic Diabetes, and Dr. Anila Bindal, Associate Medical Director at Abbott's Diabetes Care.

This episode covers the potential impact on diabetes care, market reactions, and what this means for patients globally.

00:00 Introduction and Episode Overview

00:18 Breaking News: Medtronic and Abbott Partnership

00:53 Reading the Official Press Releases

04:47 Interview with Industry Experts

05:43 Impact on the Diabetes Community

10:14 Future Expectations and Patient Benefits

18:11 Closing Thoughts and Final Remarks